Huang Y - Search Results

1

The good pain management (GPM) ward program in China and its impact on Chinese cancer patients: the SYSUCC experience.

Yang YP, Ma YX, Huang Y, Zhao YY, Xu F, Tian Y, Zou BY, Gao RZ, Zhang L. Yang YP, et al. Among authors: huang y. Chin J Cancer. 2014 Jul;33(7):323-9. doi: 10.5732/cjc.014.10031. Epub 2014 May 26. Chin J Cancer. 2014. PMID: 24874643 Free PMC article.

2

[Survival outcomes of T-cell non-Hodgkin's lymphoma: a report of 111 cases].

Huang Y, Lin TY, Wu QL, Su ZL, Huang HQ, Xia ZJ, Sun XF, Jiang WQ, Guan ZZ. Huang Y, et al. Among authors: huang hq. Ai Zheng. 2005 Apr;24(4):470-4. Ai Zheng. 2005. PMID: 15820072 Chinese.

3

[Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma].

Xiao J, Wang SS, Huang Y, Chen LK, Guan ZZ, Huang HQ, Xia ZJ, Xu RH, Lin TY. Xiao J, et al. Among authors: huang hq, huang y. Ai Zheng. 2006 Sep;25(9):1173-7. Ai Zheng. 2006. PMID: 16965665 Chinese.

4

[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].

Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY. Fu XH, et al. Among authors: huang hq, huang y. Ai Zheng. 2006 Aug;25(8):1013-8. Ai Zheng. 2006. PMID: 16965685 Chinese.

5

Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs.

Huang JJ, Li ZM, Huang Y, Huang Y, Tian Y, He XX, Xiao J, Lin TY. Huang JJ, et al. Among authors: huang y. Invest New Drugs. 2012 Feb;30(1):223-35. doi: 10.1007/s10637-010-9558-4. Epub 2010 Oct 20. Invest New Drugs. 2012. PMID: 20960030

6

Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastases.

Zhao YY, Xue C, Hou X, Liao H, Li S, Zhao HY, Huang Y, Chen LK, Xu F, Liu JL, Zhang L. Zhao YY, et al. Among authors: huang y. Eur J Cancer. 2011 Apr;47(6):848-53. doi: 10.1016/j.ejca.2010.12.004. Epub 2011 Jan 20. Eur J Cancer. 2011. PMID: 21256000 Clinical Trial.

7

EGFR inhibitors sensitize non-small cell lung cancer cells to TRAIL-induced apoptosis.

Xu F, Tian Y, Huang Y, Zhang LL, Guo ZZ, Huang JJ, Lin TY. Xu F, et al. Among authors: huang jj, huang y. Chin J Cancer. 2011 Oct;30(10):701-11. doi: 10.5732/cjc.011.10107. Chin J Cancer. 2011. PMID: 21959047 Free PMC article.

8

Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab.

Zhao YY, Xue C, Jiang W, Zhao HY, Huang Y, Feenstra K, Resau JH, Qian CN, Zhang L. Zhao YY, et al. Among authors: huang y. J Thorac Oncol. 2012 Jan;7(1):71-5. doi: 10.1097/JTO.0b013e31823085f4. J Thorac Oncol. 2012. PMID: 22011670 Free article.

9

Knockdown of nucleophosmin induces S-phase arrest in HepG2 cells.

Wang QQ, Zhang ZY, Xiao JY, Yi C, Li LZ, Huang Y, Yun JP. Wang QQ, et al. Among authors: huang y. Chin J Cancer. 2011 Dec;30(12):853-60. doi: 10.5732/cjc.011.10362. Epub 2011 Nov 18. Chin J Cancer. 2011. PMID: 22098949 Free PMC article.

10

Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy.

Zhao HY, Huang H, Hu ZH, Huang Y, Lin SX, Tian Y, Lin TY. Zhao HY, et al. Among authors: huang h, huang y. Anticancer Drugs. 2012 Jun;23(5):534-42. doi: 10.1097/CAD.0b013e32834f7ef4. Anticancer Drugs. 2012. PMID: 22481060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82,410 results

Search Page

Filters